<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04387513</url>
  </required_header>
  <id_info>
    <org_study_id>AlexandreGros</org_study_id>
    <nct_id>NCT04387513</nct_id>
  </id_info>
  <brief_title>Impact of Early Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Retrospective Study</brief_title>
  <acronym>ICE-COCA</acronym>
  <official_title>Impact of Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Multicentric,Retrospective, Propensity-score Matching Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gros, Alexandre, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gros, Alexandre, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical delay in severe endocardits, with neurological complications, is still debated.&#xD;
      Early surgery, if indicated, permits to avoid new embolic events, or to fix valvular damages,&#xD;
      but can create or increase a cerebral hemorrage.&#xD;
&#xD;
      Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in&#xD;
      severe left endocarditis, with neurological complications.&#xD;
&#xD;
      Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1&#xD;
      year, in patients with severe endocarditis, with neurological complications.&#xD;
&#xD;
      Primary endpoint:&#xD;
&#xD;
      1) Mortality at 1 year&#xD;
&#xD;
      Secondary endpoints:&#xD;
&#xD;
        1. Analyze the factors associated with neurological degradation&#xD;
&#xD;
        2. Evaluate the neurological tolerance of cardiac surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical delay in severe endocardits, with neurological complications, is still debated.&#xD;
      Early surgery, if indicated, permits to avoid new embolic events, or to fix valvular damages,&#xD;
      but can create or increase a cerebral hemorrage.&#xD;
&#xD;
      Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in&#xD;
      severe left endocarditis, with neurological complications.&#xD;
&#xD;
      Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1&#xD;
      year, in patients with severe endocarditis, with neurological complications.&#xD;
&#xD;
      Primary endpoint:&#xD;
&#xD;
      1) Mortality at 1 year&#xD;
&#xD;
      Secondary endpoints:&#xD;
&#xD;
        1. Analyze the factors associated with neurological degradation&#xD;
&#xD;
        2. Evaluate the neurological tolerance of cardiac surgery.&#xD;
&#xD;
      Methods Multicentric study (7 French university hospitals). Retrospective study: from august&#xD;
      2010 to december 2017. Propensity score matching study. 192 patients are included.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2010</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">August 18, 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>at 1 year after the diagnosis of endocarditis</time_frame>
    <description>Death from any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurogical tolerance</measure>
    <time_frame>At 6 months</time_frame>
    <description>Modified Rankin score after cardiac surgery, 0 (no symptoms at all) to 6 (death)</description>
  </secondary_outcome>
  <enrollment type="Actual">192</enrollment>
  <condition>Endocarditis</condition>
  <condition>Neurologic Complication</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac surgery</intervention_name>
    <description>Cardiac surgery, if indicated, delayed or not by neurological complications</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients in intensive care unit. They all have an indication of surgery, but&#xD;
        they are not all operated (neurological or others contre-indications).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Left endocarditis&#xD;
&#xD;
          -  With indication of cardiac surgery&#xD;
&#xD;
          -  Severe endocaditis (SOFA score &gt; or = 3/16)&#xD;
&#xD;
          -  With pre operative neurological complications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18&#xD;
&#xD;
          -  Right endocarditis without left endocarditis&#xD;
&#xD;
          -  No severe endocarditis (SOFA score &lt; 3)&#xD;
&#xD;
          -  Ne pre operative neurological complications&#xD;
&#xD;
          -  Endocarditis without indication of cardiac surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 10, 2020</study_first_submitted>
  <study_first_submitted_qc>May 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2020</study_first_posted>
  <last_update_submitted>May 17, 2020</last_update_submitted>
  <last_update_submitted_qc>May 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gros, Alexandre, M.D.</investigator_affiliation>
    <investigator_full_name>Dr Alexandre Gros</investigator_full_name>
    <investigator_title>GROS, Alexandre, Medical Doctor, Intensive Care Unit, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endocarditis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>All individual data are available in an Excel file.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

